Author/Creator: Varney, Mark A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Varney, Mark A.

1. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT1A receptor selective agonist, NLX-112 in mouse models of pain. (October 2017)

Authors:: Sałat, Kinga; Kołaczkowski, Marcin; Furgała, Anna; Rojek, Adriana; Śniecikowska, Joanna; Varney, Mark A.; Newman-Tancredi, Adrian
Journal:: Neuropharmacology
Issue:: Volume 125(2017)
Page Start:: 181
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Distinctive in vitro signal transduction profile of NLX‐112, a potent and efficacious serotonin 5‐HT1A receptor agonist. (14th June 2017)

Authors:: Newman‐Tancredi, Adrian; Martel, Jean‐Claude; Cosi, Cristina; Heusler, Peter; Lestienne, Fabrice; Varney, Mark A.; Cussac, Didier
Journal:: Journal of pharmacy and pharmacology
Issue:: Volume 69:Number 9(2017:Sep.)
Page Start:: 1178
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Effects of D‐amino acid oxidase inhibition on memory performance and long‐term potentiation in vivo. Issue 1 (1st October 2013)

Authors:: Hopkins, Seth C.; Campbell, Una C.; Heffernan, Michele L. R.; Spear, Kerry L.; Jeggo, Ross D.; Spanswick, David C.; Varney, Mark A.; Large, Thomas H.
Journal:: Pharmacology research & perspectives
Issue:: Volume 1:Issue 1(2013:Oct.)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Enhanced aggressive phenotype of Tph2 knockout rats is associated with diminished 5-HT1A receptor sensitivity. (15th July 2019)

Authors:: Peeters, Deborah G.A.; de Boer, Sietse F.; Terneusen, Anneke; Newman-Tancredi, Adrian; Varney, Mark A.; Verkes, Robbert-Jan; Homberg, Judith R.
Journal:: Neuropharmacology
Issue:: Volume 153(2019)
Page Start:: 134
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements. (June 2016)

Authors:: McCreary, Andrew C.; Varney, Mark A.; Newman-Tancredi, Adrian
Journal:: Neuropharmacology
Issue:: Volume 105(2016)
Page Start:: 651
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements. (June 2016)

Authors:: McCreary, Andrew C.; Varney, Mark A.; Newman-Tancredi, Adrian
Journal:: Neuropharmacology
Issue:: Volume 105(2016)
Page Start:: 651
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets. (1st May 2020)

Authors:: Fisher, Ria; Hikima, Atsuko; Morris, Rebecca; Jackson, Michael J.; Rose, Sarah; Varney, Mark A.; Depoortere, Ronan; Newman-Tancredi, Adrian
Journal:: Neuropharmacology
Issue:: Volume 167(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. The selective 5-HT1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. Issue 5 (9th June 2022)

Authors:: Jastrzębska-Więsek, Magdalena; Wesołowska, Anna; Kołaczkowski, Marcin; Varney, Mark A.; Newman-Tancredi, Adrian; Depoortere, RonanY.
Journal:: Behavioural pharmacology
Issue:: Volume 33:Issue 5(2022)
Page Start:: 333
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗